BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 28871046)

  • 1. Loss of OCRL increases ciliary PI(4,5)P
    Prosseda PP; Luo N; Wang B; Alvarado JA; Hu Y; Sun Y
    J Cell Sci; 2017 Oct; 130(20):3447-3454. PubMed ID: 28871046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OCRL localizes to the primary cilium: a new role for cilia in Lowe syndrome.
    Luo N; West CC; Murga-Zamalloa CA; Sun L; Anderson RM; Wells CD; Weinreb RN; Travers JB; Khanna H; Sun Y
    Hum Mol Genet; 2012 Aug; 21(15):3333-44. PubMed ID: 22543976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OCRL-mutated fibroblasts from patients with Dent-2 disease exhibit INPP5B-independent phenotypic variability relatively to Lowe syndrome cells.
    Montjean R; Aoidi R; Desbois P; Rucci J; Trichet M; Salomon R; Rendu J; Fauré J; Lunardi J; Gacon G; Billuart P; Dorseuil O
    Hum Mol Genet; 2015 Feb; 24(4):994-1006. PubMed ID: 25305077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OCRL deficiency impairs endolysosomal function in a humanized mouse model for Lowe syndrome and Dent disease.
    Festa BP; Berquez M; Gassama A; Amrein I; Ismail HM; Samardzija M; Staiano L; Luciani A; Grimm C; Nussbaum RL; De Matteis MA; Dorchies OM; Scapozza L; Wolfer DP; Devuyst O
    Hum Mol Genet; 2019 Jun; 28(12):1931-1946. PubMed ID: 30590522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oculocerebrorenal syndrome of Lowe (OCRL) controls leukemic T-cell survival by preventing excessive PI(4,5)P
    Chen H; Lu C; Tan Y; Weber-Boyvat M; Zheng J; Xu M; Xiao J; Liu S; Tang Z; Lai C; Li M; Olkkonen VM; Yan D; Zhong W
    J Biol Chem; 2023 Jun; 299(6):104812. PubMed ID: 37172724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lowe syndrome, a deficiency of phosphatidylinositol 4,5-bisphosphate 5-phosphatase in the Golgi apparatus.
    Suchy SF; Olivos-Glander IM; Nussabaum RL
    Hum Mol Genet; 1995 Dec; 4(12):2245-50. PubMed ID: 8634694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. INPP5E regulates phosphoinositide-dependent cilia transition zone function.
    Dyson JM; Conduit SE; Feeney SJ; Hakim S; DiTommaso T; Fulcher AJ; Sriratana A; Ramm G; Horan KA; Gurung R; Wicking C; Smyth I; Mitchell CA
    J Cell Biol; 2017 Jan; 216(1):247-263. PubMed ID: 27998989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional Characterization and Rescue of a Deep Intronic Mutation in OCRL Gene Responsible for Lowe Syndrome.
    Rendu J; Montjean R; Coutton C; Suri M; Chicanne G; Petiot A; Brocard J; Grunwald D; Pietri Rouxel F; Payrastre B; Lunardi J; Dorseuil O; Marty I; Fauré J
    Hum Mutat; 2017 Feb; 38(2):152-159. PubMed ID: 27790796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compensatory Role of Inositol 5-Phosphatase INPP5B to OCRL in Primary Cilia Formation in Oculocerebrorenal Syndrome of Lowe.
    Luo N; Kumar A; Conwell M; Weinreb RN; Anderson R; Sun Y
    PLoS One; 2013; 8(6):e66727. PubMed ID: 23805271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of Ciliary Phosphoinositide Content Regulates Trafficking and Sonic Hedgehog Signaling Output.
    Chávez M; Ena S; Van Sande J; de Kerchove d'Exaerde A; Schurmans S; Schiffmann SN
    Dev Cell; 2015 Aug; 34(3):338-50. PubMed ID: 26190144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular Pathology of Oculocerebrorenal Syndrome of Lowe: Novel Mutations and Genotype-Phenotype Analysis.
    Song E; Luo N; Alvarado JA; Lim M; Walnuss C; Neely D; Spandau D; Ghaffarieh A; Sun Y
    Sci Rep; 2017 May; 7(1):1442. PubMed ID: 28473699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary cilia signaling mediates intraocular pressure sensation.
    Luo N; Conwell MD; Chen X; Kettenhofen CI; Westlake CJ; Cantor LB; Wells CD; Weinreb RN; Corson TW; Spandau DF; Joos KM; Iomini C; Obukhov AG; Sun Y
    Proc Natl Acad Sci U S A; 2014 Sep; 111(35):12871-6. PubMed ID: 25143588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kidney Tubular Ablation of
    Inoue K; Balkin DM; Liu L; Nandez R; Wu Y; Tian X; Wang T; Nussbaum R; De Camilli P; Ishibe S
    J Am Soc Nephrol; 2017 May; 28(5):1399-1407. PubMed ID: 27895154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Species-specific difference in expression and splice-site choice in Inpp5b, an inositol polyphosphate 5-phosphatase paralogous to the enzyme deficient in Lowe Syndrome.
    Bothwell SP; Farber LW; Hoagland A; Nussbaum RL
    Mamm Genome; 2010 Oct; 21(9-10):458-66. PubMed ID: 20872266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 5-phosphatase OCRL in Lowe syndrome and Dent disease 2.
    De Matteis MA; Staiano L; Emma F; Devuyst O
    Nat Rev Nephrol; 2017 Aug; 13(8):455-470. PubMed ID: 28669993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell lines from kidney proximal tubules of a patient with Lowe syndrome lack OCRL inositol polyphosphate 5-phosphatase and accumulate phosphatidylinositol 4,5-bisphosphate.
    Zhang X; Hartz PA; Philip E; Racusen LC; Majerus PW
    J Biol Chem; 1998 Jan; 273(3):1574-82. PubMed ID: 9430698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The phosphoinositide 3-kinase inhibitor alpelisib restores actin organization and improves proximal tubule dysfunction in vitro and in a mouse model of Lowe syndrome and Dent disease.
    Berquez M; Gadsby JR; Festa BP; Butler R; Jackson SP; Berno V; Luciani A; Devuyst O; Gallop JL
    Kidney Int; 2020 Oct; 98(4):883-896. PubMed ID: 32919786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphoinositides Regulate Ciliary Protein Trafficking to Modulate Hedgehog Signaling.
    Garcia-Gonzalo FR; Phua SC; Roberson EC; Garcia G; Abedin M; Schurmans S; Inoue T; Reiter JF
    Dev Cell; 2015 Aug; 34(4):400-409. PubMed ID: 26305592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autophagosome-lysosome fusion triggers a lysosomal response mediated by TLR9 and controlled by OCRL.
    De Leo MG; Staiano L; Vicinanza M; Luciani A; Carissimo A; Mutarelli M; Di Campli A; Polishchuk E; Di Tullio G; Morra V; Levtchenko E; Oltrabella F; Starborg T; Santoro M; Di Bernardo D; Devuyst O; Lowe M; Medina DL; Ballabio A; De Matteis MA
    Nat Cell Biol; 2016 Aug; 18(8):839-850. PubMed ID: 27398910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional overlap between murine Inpp5b and Ocrl1 may explain why deficiency of the murine ortholog for OCRL1 does not cause Lowe syndrome in mice.
    Jänne PA; Suchy SF; Bernard D; MacDonald M; Crawley J; Grinberg A; Wynshaw-Boris A; Westphal H; Nussbaum RL
    J Clin Invest; 1998 May; 101(10):2042-53. PubMed ID: 9593760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.